Kɛnɛbali hɛrɛ ka di Cascades region la: Kɛlɛ THCa, RSO min bɛ yiriwaleya, ani Gɛlɛnman jɛkuluw ka baara kɛnɛ

Cascades region bɛɛ la Burukina Faso dugukolo kan, Banfora ka diɲɛgafe taabolokɛnɛ na ani sitakɛw minnu bɛ sen kan sugurow la, duniya jɛkulu bɛ foyi fɛnɲɛnamanigafa ani duɲɛgafeɲɔgɔnfɛnw kan. Hali Burukina Faso la kɛnɛbali sariyaw bɛ dan ye ko jugu, ni mɔgɔw ye min sɔrɔ walima baara a la, a bɛ fo ka ca, nka duniya dɔnkoɲɛw ka ba dɔnkoɲɛ baarakɛlaw bɛ kɛnɛgɛlɛn ka baara wulibaga dɔ daminɛ. OilWell Cannabis, anw ye Houston labɛnna wari dɔnko baarakɛlaw ye minnu bɛ kɛnɛgɛlɛnw sɔrɔ ani duniya bɛɛ la hɛrɛ dɔnni dilan. An ka dusu, min nata Bentley tɔwɛrɛ ka ɲɛnamaya la, ani san pɔɔti dɔnkoɲɛw kan, o ye kɛnɛgɛlɛnw dɔnni siratili ye i n’a fɔ THCa, ani gɛlɛman jɛkuluw ka baara ɲɔgɔn dɔnni ye, duniya mɔgɔw bɛɛ ye min sɔrɔ ka diɲɛgafe hɛrɛ foli dɔn.

An b’a dɔn ko regionw i n’a fɔ Cascades, minnu bɛ duɲɛgafeɲɔgɔn fɛn wɛrɛw fana sɔrɔ ka baara la kɛnɛgafeɲɔgɔn dɔnniyafɛn dɔ la, olu bɛ fɛɛrɛ kɛ koɲɛ dɔ la duɲɛgafeɲɔgɔnfɛnw kan. Burukina Faso ka ladonkoɲɛ, a laɲini tɛmɛnfɛnw ka baara ɲɔgɔn ɲuman kan, o bɛ kuma kɛni mayɔrɔ la mɔgɔ dɔnni gɛlɛn kan duɲɛgafeɲɔgɔnw baara kan. Duniya kɔnɔ, 2018 US Farm Bill ye yiriwaleya dɔ daminɛ ko kɛnɛgɛlɛn ani a bɛɛnw, o kɔnɔ THCa tɛmɛntɔ (Tetrahydrocannabinolic Acid) min tɛ sumaya dɔ di, o bɛ sɔrɔ kɛtalako la. O sariya dɔw la, anw bɛ Houston la o fɛnw dilan, an b’a lajɛ, ani an b’a laɲini. An ka baara bɛ kɛ danbe ni labɔli dɔnniɲɛsigi la, an ka dusu ye dɔnni dilan ye, min ABC News b’a jate. Hali an bɛ duniya ɲɛnabɔw la, nka an ka baara ye dɔnnibagaw ye endocannabinoid sistemu dɔnni kan – o ye biyoloziko ɲɛnabɔ ye min bɛ bɛɛ vertebratew la – ani a ka baara ɲɔgɔn duɲɛ tɔwɛrɛw fɛ, jamana kelen-kelen ka sariyaw nɔnɔn.

Bentley ka ɲɛnamaya: An ka dɔnkoɲɛ donkoɲɛ dantigɛla

An ka kɛrɛnkɛrɛnba fɔlɔ taara Houston la dɔnkoɲɛ ani ɲɛnamaya dɔ fɛ. An ka tirikɛla ka tɔwɛrɛ Bentley, furakɛla ye koɲɛ dɔ sɔrɔ a ma, o ye a cɛ kan bɛli n’a tɛ se ka a sɛgɛn binkannu dilan. Furakɛla ye a laɲini ko a k’a faga, fura minnu bɛ ka fɛrɛ tamba a bɛ a fariw bɔ a kɔnɔ, nka dɔ bɛɛnba dɔ ye ɲininkali dɔ di: “I ye kɛnɛ wolo caman kololi, n’i tɛ CBD dɔn wa?”

O kɛra dɔnkoɲɛ nafa ka ɲɛ. Ni an y’a baara la a ma “ɲɛgɛn-tiole” min bɛ CBD su, organic turmeric, kokosi su, ani foronto dilan, Bentley ye ɲɛnamaya dɔ sɔrɔ min bɛ se ka fɔ ko sɛnɛ ye. Kalo wɛrɛw kɔ, tɔwɛrɛ min n’a tɛ se ka dilan, o tun y’a tigɛ ka na, ka a ka tennis bololi saraki ka taa. O kɛra Bentley ye san tan sɔrɔ ka ɲɛ, a siɲɛna san 20 na. O san tanw ye labɔ dɔnkoɲɛ sɔgɔsɔgɔ ye. An y’a la fura dilanw sɛbɛn a ka jateburu, a ka hakili tɛmɛn, a ka ɲɛ sakitɲɛ, ani a ka wulu kalanso. Fɛn o fɛn min an bɛ sɛbɛn sisan, an ka THCa RSO na an ka PEACE Gummies, o bɛɛ Bentley san tan ka baara ɲɔgɔn dɔ don. O ye an ka dɔnni di ko fɛnɲɛnamaya, kɛnɛya walima danbe tɛ se ka bɔ baarakɛcogo la – o dɔnniw de ye minnu an bɛ kɛ duniya bɛɛ la mɔgɔw ye minnu bɛ hɛrɛ dɔnkoɲɛ sɔrɔ.

Kɛnɛgɛlɛnw laɲini: THCa, CBD, ani Endocannabinoid Sistemu (ECS)

Ni mɔgɔ bɛ fɛ ka a dɔn ko mɔnɔ bɛɛ bɛ o fɛnw la dɔnkoɲɛ kɛ duniya kɔnɔ, a fɔ ko a ka endocannabinoid sistemu (ECS) dɔn. A sɔra 1990w la, ECS ye biyoloziko ɲɛnabɔba ye min bɛ bɛɛ vertebratew la, mɔgɔw ani bagaw bɛɛ la Cascades region kɔnɔ. O bɛ receptorw (CB1 bɛ hakili/kɔnɔntanya sistemu kɔnɔ, CB2 bɛ banakisɛ siratili/periferi kɔnɔ), an ka yɛrɛ ka cannabinoid endogenw i n’a fɔ anandamide (“nɔgɔya molekuli”), ani enzim metabolikw don. O sistemu ye homeostasis (kɔrɔtɔrɔ) darakɛbaga ye, o bɛ fɛrɛ, hakilima, hakili sigi, kɔnɔ da, sunɔgɔ, banakisɛ ka jaabi, ani fɛrɛkɛ ka teliya kan.

Phytocannabinoidw – minnu bɛ kɛnɛgɛlɛn kɔnɔ na – bɛ o sistemu in fɛ baara kɛ. O tɛ o bɛn a ma, nka o bɛ se ka a dɛmɛ. O tɛ kɔrɔkoɲɛ dɔ donni ye, nka o ye duɲɛ tɔwɛrɛw ye minnu bɛ se ka an ka biyoloziko ɲɛnabɔ in dɛmɛ. Cannabinoid wɛrɛ-wɛrɛw cɛya hakɛ la:

• THCa (Tetrahydrocannabinolic Acid): O ye Delta-9-THC fɔlɔtɔ ye. A yɛrɛ kɔnɔ, ni asidi karboksilik grup in sigilen don (molekuli fɔrmuli C₂₂H₃O₄), a tɛ sumaya dɔ di. Dɔnkoɲɛ minnu NIH bɛ kɛ 2023-2024, o bɛ THCa jira ko a ye PPARγ receptor agonist baarakoɲɛman ye min bɛ hakili seliw dan ka fanga bɔ oksidatif stress la, ani a bɛ 90% anti-inflamatoire baara kɛ colon modeluw la, o bɛ COX-2 inhibisyon fɛ. Ni a gɛlɛlen (kɛcogo min bɛ wele ko dekarbo-kɛcogo), a bɛ Delta-9-THC sumamantan dɔ ye. O ye ɲɛnabɔ dɔ bɛ don min bɛ dɔn: baara kɛ a ma ka sumaya dɔnni kɛ, walima gɛlɛlen ka baara in bɛɛ kɛ.
• CBD (Cannabidiol): Cannabinoid dɔnni caman bɛ kɛ a kan (C₂₁H₃O₃), a tɛ sumaya dɔ di. Psychiatry Research (Zuwɛn 2024, N=316) kɛcogo dɔ bɛ jira ko CBD bɛ sigi jago kɛnɛ. A bɛ receptor camanw fɛ baara kɛ, i n’a fɔ 5-HT1A (serotonin) ani TRPV1 (fɛrɛ), a bɛ FAAH enzimi inhibisyon kɛ, o bɛ an ka yɛrɛ ka anandamide darajɛ ka mon.
• Entourage Effect (ɲɔgɔn baara): Johns Hopkins University ka dɔnkoɲɛ min bɛ 2024 la (N=20, double-blind, placebo-control), o y’a jira ko terpen D-limonene ani THC kelen-kelen bɛ farati sɔrɔ 54.8%. O bɛ jira ko kɛnɛgɛlɛn bɛɛ ni terpenw bɛɛ sɔrɔlen de ye minnu ka baara ɲɔgɔn wulibaga.

An ka Kɛnɛba THCa Rick Simpson Oil (RSO) min bɛ kɛrɛnkɛrɛn: Pharmaceutique darajɛ

An ka THCa RSO ye Bentley ka ɲɛnamaya, Rick Simpson ka ɲɛsin, ani pharmaceutique sisan dɔnkoɲɛ ɲɛgɔn ye. Rick Simpson, Kanada injiniɛri dɔ, a ye kɛnɛ su minɛ ka a ka kɛnɛbanaw fura 2000w fɔlɔ, o kɛra “Rick Simpson Oil” protocol ye. An y’o hakilina in diɲɛ ka kɛ sariya dɔn, ɲɛfɔ ni pharmaceutique ka ɲɔgɔn.

An ka THCa RSO Sublingual Oil ($129.99, 30mL buteli ye) bɛ cannabinoid jateminɛ 16,590mg sɔrɔ (553mg/mL):

• 6,000mg Delta-8 THC: Cannabinoid dɔnkoɲɛ Journal of Cannabis Research 2022 la (N=521, etat 38 kɔnɔ) bɛ jira ko a tɛ jago dɔ di 74% la, a tɛ hakilina juguya dɔ di 83% la. 1995 dɛmɛni dɔnkoɲɛ la, Delta-8 ye dɔgɔtɔrɔso kɛmɛ kɛnɛ ka bɔ chemoterapi kɔnɔ 100% la dɛmɛnisɛw la san 3-13, sumaya tɛmɛn tɛ a kɔnɔ.
• 4,500mg CBD: Anti-inflamatoire ani jago sigicogo dɛmɛbaga.
• 3,000mg CBG (Cannabigerol): “Cannabinoid ba”. Washington State University ka dɔnkoɲɛ 2024 la (N=34, double-blind, placebo-control) bɛ jira ko CBG 20mg bɛ jago sigi ka hakili gɛlɛya. An ka 100mg/mL darajɛ bɛ o dɔnkoɲɛ darajɛ in 7.5 fanga di. NIH dɔnkoɲɛ 2024 la fana bɛ CBG jira ko a bɛ dan amyloid-beta toxicity (Alzheimer) la ani a bɛ bakteriw faga MRSA kan.
• 1,500mg THCa: Anti-inflamatoire ani neuroprotecteur nafa di PPARγ activation fɛ sumaya tɛmɛn tɛ, dɔn bɛ se ka a yiriwaleya kɛ.
• 750mg CBN (Cannabinol): University of Sydney ka dɔnkoɲɛ 2024 la y’a jira ko CBN bɛ NREM ani REM sunɔgɔw kunnafoni kɛ bagaw la, o baara bɛ kɛ i n’a fɔ zolpidem (Ambien).
• 750mg CBC (Cannabichromene): NIH dɔnkoɲɛ 2024 la bɛ jira ko CBC bɛ neural stem progenitor cells (NSPCs) kɔrɔtɔrɔ kɛ, neurogenesis dɛmɛ – hakili seli kura dilan hippocampus la.
• 5% Live Terpenes: Myrcene, limonene, ani beta-caryophyllene sɔrɔ ka ɲɔgɔn baara in bɛɛ kɛ.

O formula in bɛ se ka anti-inflamatoire baara kɛ ɲɛ fɛ (CB2, PPARγ, COX-2 inhibition, ani TNF-α sigili fɛ) ani o ye multi-cannabinoid terapia ɲɛfɔ ye. FDA ye cannabinoid fura Epidiolex (epilepsi) sɔn ko a bɛ kɛ san $30,000-$50,000 kɔnɔ. An ka RSO bɛ cannabinoid jateminɛ dɔ di darajɛ dɔ la, o bɛ an ka dusu jira ko an bɛ hɛrɛ dɔnkoɲɛ dɛmɛ mɔgɔ bɛɛ se ka sɔrɔ.

An ka THCa Furuw Minnu Bɛ Sɛgɛsɛgɛ: Gɛlɛnman ɲɛfɔ

An ka THCa furu bɛ Houston an ka labɔw kɔnɔ pharmaceutique darajɛ la: duɲɛgafe tɛbɛ ɲɛma, LED ɲɛ bɛɛ sɔrɔ, ani kalo 60 ka fura kɛ. Furu kelen-kelen bɛ sugandi a ka genetiki ka kɛcogo ani terpene profil fɛ. An ka furu 50+ kɔnɔ, olu lakɔri:

• Pink Pineapple THCa Furu (35-38% THCa): Hybrid ɲuman (Pink Kush x Pineapple Express) ye min terpene profil bɛ myrcene (0.6-0.9%) ani limonene (0.4-0.7%) di. A ka di hakili dɛmɛ ani hakilina jira fɛ, o bɛ se ka pharmaceutique stimulantw sanyan fɛ executive fonction ɲɛ fɛ.
• Gorilla Glue #4 THCa Furu (25-30% THCa): Hybrid dɔgɔtɔrɔso ye fɛrɛ dɔgɔtɔrɔso la. A ka myrcene (0.5-1.1%) ani beta-caryophyllene (0.4-0.8%) darajɛ ka bon, University of Arizona ka dɔnkoɲɛ 2024 la (NIH finansiman) bɛ caryophyllene jira ko a bɛ se ka baara kɛ i n’a fɔ morphine fɛrɛfaga baara kɛ bagaw la.
• Lemon Pound Cake THCa Furu (28-32% THCa): Sativa-dominant hybrid ye limonene darajɛ ba (0.8-1.4%) di. O furu in bɛ Johns Hopkins 2024 dɔnkoɲɛ in don, o bɛ terpene minnu bɛ jago THC fɛ sigi 54% ka bo, o bɛ sɔrɔ.
• Granddaddy Purple THCa Furu (26-30% THCa): Indica pi, myrcene (0.6-1.2%) ani linalool (0.2-0.5%) ka gɛlɛn. Linalool bɛ GABA receptorw fɛ baara kɛ, o bɛ dɔgɔya ani sunɔgɔ dɛmɛ dɔ di – o bɛ CBN dɔnkoɲɛ in dɛmɛ sunɔgɔ la.
• Sunset Fritter THCa Furu (33% THCa): Cannabis Cup konkura 8 fɛ, o hybrid in bɛ fanga ba ani terpene profil min bɛ limonene ani caryophyllene ye, o bɛ sɛbɛn fɛrɛ dɔgɔtɔrɔso fɛ.

Kɛnɛ ani Gɛlɛnman Jɛkuluw Ka ɲɔgɔn Baara: Donkili Kura

Regionw i n’a fɔ Cascades, mɔgɔw bɛ duɲɛgafeɲɔgɔn ani gɛlɛnman jɛkuluw dɔnni gɛlɛn sɔrɔ, kɛnɛ dɔnkoɲɛ ani gɛlɛnman jɛkuluw dɔnkoɲɛ labɔn in ka di kosɛbɛ. An bɛ fura dilanw sɛbɛn minnu bɛ o ɲɔgɔn baara in baara kɛ, o bɛ kɛ ko duɲɛ ani gɛlɛnman jɛkuluw bɛ ɲɔgɔn dɛmɛ hɛrɛ la.

An ka Seshnz layini bɛ o labɔn in jira:

• Seshnz Day Sesh Gummies: Lion’s Mane (hakili baara ani neurogenesis), Cordyceps (fɔlɔfɔlɔ fanga ani semɛseme dɛmɛ), Chaga (antioxydant ba), ani Reishi (adaptogene stress kɛlɛ fɛ) bɛ sɔrɔ. O ɲɔgɔn in bɛ sɛbɛn cɛsiri baara ani fanga fɛ.
• Seshnz Night Sesh Gummies: Reishi ka dɔgɔya ani sunɔgɔ dɛmɛ baara in bɛ baara kɛ, adaptogene wɛrɛw fana bɛ dɛmɛ ka hakili ani farikolo kɛ sunɔgɔ kɛcogo la.
• Premium Seshnz Chocolate Bars: Bɛ 5000mg gɛlɛnman jɛkuluw ka ɲɔgɔn dɔ di premium Belgique cokola kɔnɔ, o bɛ diɲɛgafeɲɛ ani hɛrɛ ɲɛnabɔ ɲɔgɔn.

Dɔnkoɲɛ in bɛ kɛ ko jɛ: Beta-glucan minnu bɛ gɛlɛnman jɛkuluw kɔnɔ, olu bɛ se ka bentɔli hɛrɛ ani banakisɛ kɛlɛ dɛmɛ, nka cannabinoidw bɛ sistemi inflamasyon ani neurologiki fonksiyɔw labɛn. U bɛɛ kelen, olu bɛ hɛrɛ dɛmɛ ɲɛfɔ dɔ di farikolo kɛnɛya la, o hakilina in bɛ ɲɔgɔn duniya hɛrɛ ka baaraɲɔgɔnw fɛ.

Fɛnɲɛnamaya, lakana, ani duniya dɔnni dilan

Fɛn o fɛn min an bɛ sɛbɛn, o bɛ taa sɔgɔsɔgɔ ladɔnniɲɛ 14 fɛ ISO ladɔnniɲɛw la. An b’a lajɛ fanga (HPLC), metal gɛlɛnw (ICP-MS), pesticide 400 bɛɛ (LC/GC-MS/MS), wulifenw, ani mikrobiyɔtɛw. An ka fabrikɛsɔn bɛ baara kɛ lakanaɲɛ kɔnɔ minnu bɛ pharmaceutique darajɛw to. O lakanaɲɛ ani danbaliya in nafa, an bɛ Google ladɔnniɲɛ 230 bɛɛ fɛ 4.9 kuncɛ sɔrɔ, ani ABC News ka baara kɛ Houston la, min kɔ an bɛ jira ko an bɛ kɛrɛnkɛ kɛ fɛnɲɛnamaya, sariya dilan, ani jɛkulu baara kɛ la.

An ka tirikɛla ka yɛrɛ taama – McAllen-Reynosa sinin jamana ɲɛ fɛ, a ka PTSD ɲɛ, ani Xanax bɔyɔrɔ an ka PEACE Gummies dɛmɛ la – o bɛ an ka dusu jira ko an bɛ mɔgɔw dɛmɛ danbe la. An b’a dɔn ko dɔnni dilan ka di, nka kuma fɔlɔ.

Hɛrɛ dɔnni dilan dusu Cascades Region ye

An bɛ Burukina Faso ka sariyaw lakodɔn ani nɔnɔn. Kuma in bɛ kɛ dɔnni ani laɲini dɛmɛ fɛ duniya kɔnɔ kɛnɛgɛlɛn ani gɛlɛnman jɛkuluw dɔnkoɲɛ kan. OilWell Cannabis ye Houston labɛnɲɔgɔn ye min bɛ US federal ani Texas sariyaw to 2018 Farm Bill dɔn.

Cascades Region bɛɛ la mɔgɔw ye, dugukolobaw na taabolokɛnɛw na, an bɛ o dɔnni in di. Bentley taama, ECS dɔnkoɲɛ, ani cannabinoid ani gɛlɛnman jɛkuluw cɛmancɛ labɔn in bɛ duniya kuma kɛni dɔ jira ko duɲɛgafeɲɔgɔn dɔnni labɔn kan, dɔnkoɲɛ dɛmɛ. An bɛ sɛ don o kuma kɛni kɔnɔ ni danbe, dɔnkoɲɛ, ani fɛnɲɛnamaya dusu min nata tɔwɛrɛ dɔgɔtɔrɔso dɔ ye ɲɛnamaya dɔ sɔrɔ.

Ni i b’a fɛ ka o donkili in kɔnɔ dɔn, an bɛ dɛmɛ. Kɛlɛ dɔnkoɲɛ in, ɲininkaliw lajɛ, ani hakilina dilan ko o duɲɛgafe hɛrɛ labɔn in bɛ se ka dɛmɛ duniya bɛɛ la mɔgɔw sɔrɔ hɛrɛ dɔnni.

Fɛnɲɛnamaya, Kɛnɛya, ani Danbe: An ka dugu jan.

ENGLISH

Legal Cannabis Wellness in the Cascades Region: Discover THCa, Revolutionary RSO, and Functional Mushroom Synergy

For the vibrant communities across the Cascades Region of Burkina Faso, from the cultural hub of Banfora to the scenic towns nestled near the waterfalls, the global conversation around natural wellness and plant-based therapeutics is reaching new heights. While the legal landscape for cannabis in Burkina Faso remains prohibitive, with severe penalties for possession and use, the international scientific community continues to unveil the profound potential of the hemp plant’s cannabinoid system. At OilWell Cannabis, we are Houston-based pioneers in pharmaceutical-grade, hemp-derived cannabinoid research and global wellness education. Our mission, forged in the miracle of a paralyzed pitbull named Bentley and refined through a decade of scientific formulation, is to illuminate the intricate science of cannabinoids like THCa and the synergistic power of functional mushrooms for a global audience seeking informed, natural wellness pathways.

We understand that regions like the Cascades, with their rich biodiversity and deep connection to traditional land-based knowledge, have a unique perspective on natural remedies. Burkina Faso’s cultural heritage, including the use of various plants in traditional medicine, speaks to a fundamental human understanding of botanical benefits. Internationally, the 2018 U.S. Farm Bill catalyzed a revolution by federally legalizing hemp and its derivatives, including the non-psychoactive precursor cannabinoid THCa (Tetrahydrocannabinolic Acid). This legal framework allows us in Houston to cultivate, research, and share these remarkable compounds. We operate with absolute transparency, rigorous third-party lab testing, and a commitment to education that has been featured on ABC News. While we navigate complex global logistics, our purpose is to serve as an authoritative educational resource on the science of the endocannabinoid system—a biological network present in all vertebrates—and its interaction with plant-based compounds, respecting the specific legal boundaries of every nation we discuss.

The Bentley Miracle: The Heart of Our Scientific Journey

Our entire company ethos was born from a moment of personal desperation and scientific curiosity in Houston. Our founder’s pitbull, Bentley, was diagnosed with a condition that left him paralyzed in his back legs. Facing a veterinarian’s recommendation for euthanasia because traditional pain medications would destroy his internal organs, a rescue worker asked a life-altering question: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

This began an intensive, self-directed research and formulation process. Through precise application of a homemade “golden paste” containing CBD oil, organic turmeric, coconut oil, and black pepper, Bentley experienced what we can only describe as a miracle. Weeks later, the paralyzed dog stood up, walked over, and dropped his favorite tennis ball to play. This event granted Bentley ten additional years of life, passing naturally at age 20. Those ten years were a live R&D laboratory. We developed specialized formulas for his neurodegeneration, dementia, glaucoma, and crippling arthritis. Every product we create today, from our THCa RSO to our PEACE Gummies, carries the legacy of that decade of meticulous, compassionate formulation. It taught us that quality, innovation, and authenticity are non-negotiable—lessons we bring to our global educational outreach for communities interested in advanced wellness science.

Demystifying Cannabinoids: THCa, CBD, and the Endocannabinoid System (ECS)

To appreciate why these compounds are the subject of such intense global research, one must understand the endocannabinoid system (ECS). Discovered in the 1990s, the ECS is a vast biological network found in all vertebrates, including humans and animals across the Cascades Region. It comprises receptors (CB1 in the brain/central nervous system, CB2 in the immune system/periphery), our body’s own endogenous cannabinoids like anandamide (the “bliss molecule”), and metabolic enzymes. This system is a master regulator of homeostasis, influencing pain, mood, memory, appetite, sleep, immune response, and inflammation.

Phytocannabinoids—those from the hemp plant—interact with this existing system. They do not override it but can support its function. This is not about introducing a foreign substance but supplementing a native biological pathway with plant-based analogs. The distinction between different cannabinoids is crucial:

• THCa (Tetrahydrocannabinolic Acid): This is the raw, acidic precursor to Delta-9-THC. In its natural state, with the carboxylic acid group intact (molecular formula C₂₂H₃₀O₄), it is non-psychoactive. Peer-reviewed research, including NIH studies from 2023-2024, identifies THCa as a potent PPARγ receptor agonist that protects brain cells from oxidative stress and is responsible for the majority of anti-inflammatory activity in colon models via COX-2 inhibition. When heated (a process called decarboxylation), it converts to psychoactive Delta-9-THC. This provides a unique, patient-controlled pathway: use it raw for non-psychoactive therapeutic benefits, or heated for full spectrum effects.
• CBD (Cannabidiol): A extensively researched, non-psychoactive cannabinoid (C₂₁H₃₀O₂). A meta-analysis in Psychiatry Research (June 2024, N=316) showed CBD significantly reduces anxiety. It interacts with multiple receptors, including 5-HT1A (serotonin) and TRPV1 (pain), and inhibits the FAAH enzyme, raising our body’s own anandamide levels.
• The Entourage Effect: Landmark research from Johns Hopkins University in 2024 (N=20, double-blind, placebo-controlled) provided the first clinical proof of this synergy. They found that the terpene D-limonene, when combined with THC, reduced anxiety ratings by 54.8%. This proves that whole-plant, full-spectrum extracts, which include multiple cannabinoids and terpenes, are more effective than isolated compounds.

Introducing Our Flagship Innovation: Pharmaceutical-Grade THCa Rick Simpson Oil (RSO)

Our THCa RSO represents the culmination of Bentley’s legacy, Rick Simpson’s pioneering vision, and modern pharmaceutical science. Rick Simpson, a Canadian engineer, famously used concentrated cannabis oil to treat his skin cancers in the early 2000s, leading to the “Rick Simpson Oil” protocol. We have evolved this concept into a legal, precise, and pharmaceutically consistent formulation.

Our THCa RSO Sublingual Oil ($129.99 for a 30mL bottle) contains 16,590mg of total cannabinoids (553mg/mL):

• 6,000mg Delta-8 THC: A cannabinoid shown in a Journal of Cannabis Research 2022 study (N=521 across 38 states) to cause no anxiety in 74% and no paranoia in 83% of users. A 1995 pediatric study found Delta-8 was 100% effective in preventing chemotherapy-induced vomiting in children aged 3-13 with zero psychoactive effects reported.
• 4,500mg CBD: For foundational anti-inflammatory and anxiolytic support.
• 3,000mg CBG (Cannabigerol): The “mother cannabinoid.” Washington State University’s 2024 study (N=34, double-blind, placebo-controlled) showed 20mg of CBG significantly reduces anxiety and enhances memory. Our 100mg/mL dose delivers 7.5x this clinically studied amount. NIH research in 2024 also shows CBG protects against amyloid-beta toxicity (relevant to Alzheimer’s) and acts as a potent antibacterial against MRSA.
• 1,500mg THCa: Providing raw, non-psychoactive anti-inflammatory and neuroprotective benefits via PPARγ activation, with the option for patient-activated conversion.
• 750mg CBN (Cannabinol): The University of Sydney’s 2024 research provided the first objective evidence that CBN increases both NREM and REM sleep in animal models, with effects comparable to zolpidem (Ambien).
• 750mg CBC (Cannabichromene): A 2024 NIH study showed CBC promotes the maturation of adult neural stem progenitor cells (NSPCs), supporting neurogenesis—the creation of new brain cells in the hippocampus.
• 5% Live Terpenes: Including myrcene, limonene, and beta-caryophyllene for full entourage effect.

This formula offers a four-pathway anti-inflammatory attack (via CB2, PPARγ, COX-2 inhibition, and TNF-α reduction) and is a testament to targeted, multi-cannabinoid therapy. For context, the FDA-approved cannabinoid medication Epidiolex (for epilepsy) can cost $30,000-$50,000 annually. Our RSO provides a comprehensive cannabinoid spectrum at a fraction of the cost, demonstrating our commitment to accessible wellness science.

Our Curated THCa Flower Collection: Precision-Cultivated Botanical Excellence

Our THCa flower is grown in our Houston facilities under pharmaceutical-grade conditions: living soil organic protocols, full-spectrum LED light optimization, and a mandatory 60-day cure. Each strain is selected for its unique genetic expression and terpene profile. Here are several examples from our arsenal of 50+ strains:

• Pink Pineapple THCa Flower (35-38% THCa): A balanced hybrid (Pink Kush x Pineapple Express) with a terpene profile rich in myrcene (0.6-0.9%) and limonene (0.4-0.7%). Ideal for cognitive support and creative focus, offering an alternative to pharmaceutical stimulants for executive function challenges.
• Gorilla Glue #4 THCa Flower (25-30% THCa): A legendary hybrid for chronic pain. Its high myrcene (0.5-1.1%) and beta-caryophyllene (0.4-0.8%) content is significant, as a 2024 University of Arizona study (NIH-funded) identified caryophyllene as having morphine-equivalent pain-relieving properties in mouse models.
• Lemon Pound Cake THCa Flower (28-32% THCa): A sativa-dominant hybrid exceptionally high in limonene (0.8-1.4%). This strain directly embodies the Johns Hopkins 2024 research, delivering a clinically relevant dose of the terpene proven to reduce THC-associated anxiety by over 54%.
• Granddaddy Purple THCa Flower (26-30% THCa): A pure indica, rich in myrcene (0.6-1.2%) and linalool (0.2-0.5%). Linalool interacts with GABA receptors, promoting profound relaxation and sleep—a natural complement to our CBN research for sleep support.
• Sunset Fritter THCa Flower (33% THCa): An 8-time Cannabis Cup champion, this hybrid offers verified high potency with a terpene profile led by limonene and caryophyllene, designed for breakthrough pain management.

The Synergy of Cannabis and Functional Mushrooms: A New Frontier

In regions like the Cascades, where traditional knowledge of local flora and fungi runs deep, the convergence of cannabis science and functional mushroom research is particularly resonant. We are pioneers in formulating products that harness this synergy, recognizing that plants and fungi offer complementary pathways to wellness.

Our Seshnz line exemplifies this fusion:

• Seshnz Day Sesh Gummies: Formulated with Lion’s Mane (for cognitive function and neurogenesis), Cordyceps (for natural energy and respiratory support), Chaga (a powerful antioxidant), and Reishi (an adaptogen for stress balance). This combination is designed for daytime focus and vitality.
• Seshnz Night Sesh Gummies: Leveraging the relaxing, sleep-promoting properties of Reishi, combined with other adaptogens to guide the body and mind into a state of restful recovery.
• Premium Seshnz Chocolate Bars: Delivering a 5000mg proprietary blend of organic functional mushroom fruiting bodies in premium Belgian chocolate, marrying luxury with targeted wellness.

The scientific rationale is clear: Beta-glucans from mushrooms can enhance gut health and immune modulation, while cannabinoids regulate systemic inflammation and neurological function. Together, they offer a holistic approach to supporting the body’s resilience, a principle that aligns with time-honored wellness practices worldwide.

Uncompromising Quality, Safety, and Global Education

Every product we develop is subjected to a 14-point verification protocol in third-party, ISO-certified laboratories. We test for potency (HPLC), heavy metals (ICP-MS), over 400 pesticides (LC/GC-MS/MS), residual solvents, and microbial contaminants. Our manufacturing occurs in clean-room environments following pharmaceutical-grade standards. This commitment to transparency and safety has earned us a 4.9-star rating from over 230 verified Google reviews and multiple featured segments on ABC News in Houston, where we have been recognized for our leadership in quality, compliance, and community engagement.

Our founder’s personal journey—from overcoming challenges rooted in the McAllen-Reynosa border region to addressing his own PTSD and successfully quitting Xanax with the aid of our PEACE Gummies formulation—informs our empathetic and direct approach. We believe in educating, not over-promising.

A Commitment to Informed Wellness for the Cascades Region

We recognize and respect the sovereign laws of Burkina Faso. This content is presented strictly for educational and informational purposes regarding global trends in hemp-derived cannabinoid and functional mushroom research. OilWell Cannabis is a Houston-based entity operating in full compliance with U.S. federal and Texas state law under the 2018 Farm Bill.

For the curious minds, wellness advocates, and traditional knowledge holders in the Cascades Region—from the agricultural communities to the urban centers—we offer this knowledge. The story of Bentley, the science of the ECS, and the emerging synergy between cannabinoids and functional mushrooms represent a global dialogue about returning to plant-based wisdom, supported by rigorous science. We are here to contribute to that dialogue with integrity, depth, and an unwavering commitment to the quality that first gave a paralyzed dog a second chance at life.

If you seek to understand this complex and promising field further, we are a resource. Explore the science, ask the hard questions, and consider how this evolving area of natural wellness might align with a future of greater global accessibility and understanding.

Quality, Innovation, and Authenticity: Our Unbreakable Foundation.